Fibrocor Therapeutics Announces Partnership with Galapagos NV

Fibrocor Therapeutics and Galapagos NV, a Belgo-Dutch pharmaceutical research company, have announced the formation of a partnership for the development of therapeutics to treat fibrotic diseases of the kidney and other organs.

Click here to learn more

Previous
Previous

Apply for the Canada Summer Jobs Program

Next
Next

Dot Health CEO and Founder Featured in Vogue